16. Pain in chronic pancreatitis.

IF 2.5 3区 医学 Q2 ANESTHESIOLOGY
Pain Practice Pub Date : 2025-04-01 DOI:10.1111/papr.70030
Laura van Zeggeren, Raha Boelens Nabbi, Jan Willem Kallewaard, Monique Steegers, Steven P Cohen, Leonardo Kapural, Hjalmar van Santvoort, André Wolff
{"title":"16. Pain in chronic pancreatitis.","authors":"Laura van Zeggeren, Raha Boelens Nabbi, Jan Willem Kallewaard, Monique Steegers, Steven P Cohen, Leonardo Kapural, Hjalmar van Santvoort, André Wolff","doi":"10.1111/papr.70030","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic pancreatitis is defined as a disease of the pancreas in which recurrent inflammatory episodes result in replacement of the pancreatic parenchyma by fibrous connective tissue in individuals with genetic, environmental, and other risk factors. Pain is one of the most important symptoms of chronic pancreatitis and, in many cases, has chronic visceral nociceptive, nociplastic, and even neuropathic components, with evidence of both central and peripheral sensitization, neuroplasticity, and neurogenic inflammation.</p><p><strong>Methods: </strong>The literature on the diagnosis and treatment of pain in chronic pancreatitis was reviewed and summarized.</p><p><strong>Results: </strong>Treatment of abdominal pain in chronic pancreatitis is guided by pancreatic morphology on imaging, although the correlation between pain symptoms and pathoanatomical changes is not always straightforward. Patients with pancreatic duct obstruction are initially offered endoscopic or surgical therapies, while non-obstructive disease is mostly managed medically. Lifestyle changes and psychological support are of particular importance for all chronic pancreatitis patients. Analgesic options range from non-opioid medications to opioids and adjuvant agents. Interventional pain management may consist of radiofrequency treatment of the splanchnic nerves and spinal cord stimulation. To date, there are no randomized trials supporting their efficacy in the treatment of chronic pancreatitis pain, and the recommendation to consider these treatment options is justified by evidence from observational studies. Possible opioid-sparing effects of interventional pain treatments are important to consider because opioid use and dependency are common in chronic pancreatitis patients and associated with worse outcomes. Celiac plexus block is not generally recommended for chronic pancreatitis due to the limited quality of evidence, overall short duration of effect, and invasiveness of the procedure. Central sensitization can impact the effectiveness of invasive treatments.</p><p><strong>Conclusions: </strong>Managing pain in chronic pancreatitis is a complex task that requires a multidimensional and individualized approach. Due to the lack of randomized trials, treatment decisions are often guided by expert opinion. Integrating pharmacological and non-pharmacological interventions and collaborating with a multidisciplinary team are key components of effective chronic pancreatitis pain management.</p>","PeriodicalId":19974,"journal":{"name":"Pain Practice","volume":"25 4","pages":"e70030"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11973027/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/papr.70030","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Chronic pancreatitis is defined as a disease of the pancreas in which recurrent inflammatory episodes result in replacement of the pancreatic parenchyma by fibrous connective tissue in individuals with genetic, environmental, and other risk factors. Pain is one of the most important symptoms of chronic pancreatitis and, in many cases, has chronic visceral nociceptive, nociplastic, and even neuropathic components, with evidence of both central and peripheral sensitization, neuroplasticity, and neurogenic inflammation.

Methods: The literature on the diagnosis and treatment of pain in chronic pancreatitis was reviewed and summarized.

Results: Treatment of abdominal pain in chronic pancreatitis is guided by pancreatic morphology on imaging, although the correlation between pain symptoms and pathoanatomical changes is not always straightforward. Patients with pancreatic duct obstruction are initially offered endoscopic or surgical therapies, while non-obstructive disease is mostly managed medically. Lifestyle changes and psychological support are of particular importance for all chronic pancreatitis patients. Analgesic options range from non-opioid medications to opioids and adjuvant agents. Interventional pain management may consist of radiofrequency treatment of the splanchnic nerves and spinal cord stimulation. To date, there are no randomized trials supporting their efficacy in the treatment of chronic pancreatitis pain, and the recommendation to consider these treatment options is justified by evidence from observational studies. Possible opioid-sparing effects of interventional pain treatments are important to consider because opioid use and dependency are common in chronic pancreatitis patients and associated with worse outcomes. Celiac plexus block is not generally recommended for chronic pancreatitis due to the limited quality of evidence, overall short duration of effect, and invasiveness of the procedure. Central sensitization can impact the effectiveness of invasive treatments.

Conclusions: Managing pain in chronic pancreatitis is a complex task that requires a multidimensional and individualized approach. Due to the lack of randomized trials, treatment decisions are often guided by expert opinion. Integrating pharmacological and non-pharmacological interventions and collaborating with a multidisciplinary team are key components of effective chronic pancreatitis pain management.

16. 慢性胰腺炎的疼痛。
慢性胰腺炎被定义为一种胰腺疾病,在遗传、环境和其他危险因素的个体中,复发性炎症发作导致胰腺实质被纤维结缔组织取代。疼痛是慢性胰腺炎最重要的症状之一,在许多情况下,疼痛具有慢性内脏伤害性、伤害性甚至神经性成分,具有中枢和外周致敏、神经可塑性和神经源性炎症的证据。方法:回顾和总结有关慢性胰腺炎疼痛诊断和治疗的文献。结果:慢性胰腺炎腹痛的治疗以胰腺影像学形态为指导,尽管疼痛症状与病理解剖变化之间的相关性并不总是直接的。胰管梗阻患者最初可接受内镜或手术治疗,而非梗阻性疾病大多采用药物治疗。生活方式的改变和心理支持对所有慢性胰腺炎患者尤为重要。镇痛药的选择范围从非阿片类药物到阿片类药物和辅助剂。介入性疼痛管理可能包括射频治疗内脏神经和脊髓刺激。到目前为止,还没有随机试验支持它们治疗慢性胰腺炎疼痛的疗效,观察性研究的证据证明了考虑这些治疗方案的建议是合理的。由于阿片类药物的使用和依赖在慢性胰腺炎患者中很常见,并且与较差的预后相关,因此考虑介入性疼痛治疗可能产生的阿片类药物节约效应是很重要的。由于证据质量有限、总体效果持续时间短以及手术的侵入性,腹腔神经丛阻滞通常不推荐用于慢性胰腺炎。中枢致敏可影响侵入性治疗的有效性。结论:慢性胰腺炎的疼痛管理是一项复杂的任务,需要多维和个性化的方法。由于缺乏随机试验,治疗决策往往由专家意见指导。整合药物和非药物干预以及与多学科团队合作是有效的慢性胰腺炎疼痛管理的关键组成部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pain Practice
Pain Practice ANESTHESIOLOGY-CLINICAL NEUROLOGY
CiteScore
5.60
自引率
3.80%
发文量
92
审稿时长
6-12 weeks
期刊介绍: Pain Practice, the official journal of the World Institute of Pain, publishes international multidisciplinary articles on pain and analgesia that provide its readership with up-to-date research, evaluation methods, and techniques for pain management. Special sections including the Consultant’s Corner, Images in Pain Practice, Case Studies from Mayo, Tutorials, and the Evidence-Based Medicine combine to give pain researchers, pain clinicians and pain fellows in training a systematic approach to continuing education in pain medicine. Prior to publication, all articles and reviews undergo peer review by at least two experts in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信